Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
Hepatitis C virus (HCV) is transmitted between hepatocytes via classical cell entry but also uses direct cell-cell transfer to infect neighboring hepatocytes. Viral cell-cell transmission has been shown to play an important role in viral persistence allowing evasion from neutralizing antibodies. In...
Enregistré dans:
Auteurs principaux: | Fei Xiao, Isabel Fofana, Laura Heydmann, Heidi Barth, Eric Soulier, François Habersetzer, Michel Doffoël, Jens Bukh, Arvind H Patel, Mirjam B Zeisel, Thomas F Baumert |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3d82659e652242da9ba2435e2b6c3d43 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
par: Kamal SM
Publié: (2014) -
DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
par: D. E. Valutite, et autres
Publié: (2018) -
‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant
par: Fabrizio Fabrizi, et autres
Publié: (2021) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
par: Vicente Soriano, et autres
Publié: (2022) -
The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
par: Irina RUSU, et autres
Publié: (2020)